Stella Pharma Corporation (4888.T)
JPY 555.0
(0.18%)
JPY 555.0
(0.18%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 933.3 Million JPY | -14.64% |
| 2022 | 1.09 Billion JPY | -12.77% |
| 2021 | 1.25 Billion JPY | -11.32% |
| 2020 | 1.41 Billion JPY | -10.17% |
| 2019 | 1.57 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 893.29 Million JPY | -4.29% |
| 2023 Q3 | 973.3 Million JPY | -3.95% |
| 2023 FY | 933.3 Million JPY | -14.64% |
| 2023 Q2 | 1.01 Billion JPY | -3.8% |
| 2023 Q1 | 1.05 Billion JPY | -3.66% |
| 2023 Q4 | 933.3 Million JPY | -4.11% |
| 2022 Q2 | 1.17 Billion JPY | 0.0% |
| 2022 Q3 | 1.13 Billion JPY | -3.41% |
| 2022 Q4 | 1.09 Billion JPY | -3.53% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 62.21% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 74.772% |
| Linical Co., Ltd. | 3 Billion JPY | 68.91% |
| Trans Genic Inc. | 2.25 Billion JPY | 58.65% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -40355.137% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 62.242% |
| AnGes, Inc. | 362.67 Million JPY | -157.338% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -773.476% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 98.738% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -295.496% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 15.837% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -410.081% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -5.443% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -153.809% |
| Chiome Bioscience Inc. | 291 Million JPY | -220.722% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 63.755% |
| PeptiDream Inc. | 22.79 Billion JPY | 95.907% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -196.126% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -40.346% |
| Healios K.K. | 4.53 Billion JPY | 79.406% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -729.6% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -553.329% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -856.819% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 3.585% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -28.921% |
| StemCell Institute Inc. | 8.78 Million JPY | -10525.0% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -517.058% |